Ocular Therapeutix, Inc.

OCULNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
6.21 USD
↘ 0.07 (1.11%)AT CLOSE (03:59 PM EST)
6.13
↘ 0.08 (1.29%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
6.13
↘ 0.08 (1.29%)
🔴Market: CLOSED

OCUL is currently priced at $6.21. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$6.27
High?$6.38
Low?$6.00
Prev. Close?$6.28
Volume?2.5M
Avg. Volume?2.9M
VWAP?$6.16
Rel. Volume?0.84x
Bid / Ask
Bid?$6.05 × 400
Ask?$6.21 × 300
Spread?$0.16
Midpoint?$6.13
Valuation & Ratios
Market Cap?1.4B
Shares Out?219.6M
Float?190.6M
Float %?86.8%
P/E Ratio?N/A
P/B Ratio?3.10
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsMedical Devices & HealthTech›Wearable Medical Devices
Employees
325
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ocutx.com
Listed
2014-07-25
Address
14 CROSBY DRIVE, 3RD FLOOR
BEDFORD, MA 01730
Phone: 781-357-4000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
10
Momentum?
10
Short Sent.?
19
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.92Distress
Confidence?70%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?15.21%High
Short Interest?29.0M
Days to Cover?10.1
Free Float190.6M
Avg Daily Volume2.9M
Settlement Date2026-10-30
Financial Health
Current Ratio?9.12Strong
Quick Ratio?9.05Strong
Cash Ratio?8.42Strong
Debt/Equity?0.17Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
54
3.10FAIR▾
P/S?
Peers
100
S&P
3
27.10HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.7CHEAP▾
EV/Sales?
Peers
100
S&P
3
18.03HIGH▾
Returns & Efficiency
ROE?
S&P
3
-74.1%WEAK▾
ROA?
S&P
3
-54.0%WEAK▾
Cash Flow & Enterprise
FCF?$-267035000
Enterprise Value?$908.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist